May. 7 at 8:08 PM
$TNDM Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$0.30 up 84.77% YoY
• Reported revenue of
$247.22M up 5.46% YoY
• Tandem Diabetes Care reaffirmed its financial guidance for the year ending December 31, 2026, estimating sales between
$1.07B and
$1.09B, with gross margin at 56% to 57% and Adjusted EBITDA margin at 5% to 6% of sales.